ADDUS HOMECARE CORP (ADUS)
Health Care · Home health and hospice care services · NASDAQ
A leading provider of home-based personal care, hospice, and home health services designed to lower healthcare costs by keeping aging populations independent in their own homes.
What ADDUS HOMECARE CORP does
Addus HomeCare provides personal care, hospice, and home health services to elderly and infirm individuals, primarily through in-home care delivery. The company serves a predominantly dual-eligible population (Medicare and Medicaid) and focuses on enabling clients to maintain independence at home while lowering overall healthcare costs by preventing institutionalization. Addus operates across 23 states and actively pursues growth through both organic means and strategic acquisitions.
Themes: home-based care, aging population / elderly care, Medicare Advantage / Medicaid managed care, chronic disease management, healthcare cost reduction
Fundamentals
- Price$114.26 as of 2026-10-08 close
- Market cap$2.1B as of 2026-07-28 (share count; price 2026-10-08)
- 1-year return-0.0% 2025-10-08 close $114.27 → 2026-10-08 close $114.26
- P/E20.03 as of 2026-10-08
- Net margin+6.7% FY2025, SEC XBRL
- Gross margin+32.5% FY2025, SEC XBRL
- ROE+8.8% FY2025, SEC XBRL
- Debt / equity0.05 as of 2026-09-03
- Revenue growth (YoY)+15.9% as of 2026-09-03
- Revenue CAGR (3y)+14.4% SEC XBRL
- Beta0.39 as of 2026-09-03
- Last reported earnings2026-08-03 SEC EDGAR Form 8-K (Item 2.02)
How ADUS compares in its sector
- price-to-earnings ratiomiddle range 185 covered Health Care peers, as of 2026-10-08
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-03
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-03
- gross marginbottom 25% 189 covered Health Care peers, as of 2026-09-03
- return on equitytop 25% 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
ADUS is not currently in any published Top 10 list. Its scores are below.
Top 10 score
56.7 #374 of 1,379 scored · #46 of 151 in Health Care
Valuation 76th (price to earnings 20, price to book 1.9) and growth 72nd (3-year revenue CAGR 14.4%, revenue growth year over year 15.9%); weakest is capital return (16th, net share count bought back over the year -5.8, consecutive years of dividend increases 0 years).
Scores as of 8 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
How ADDUS HOMECARE CORP looks technically
ADDUS HOMECARE CORP (ADUS) is trading 8.0% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 40 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 16, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 49, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 1 trading day ago (its momentum flipped positive). It made a new 20-day low about 7 trading days ago.
Trend
8
| Distance from the 200-day | it is trading 8.0% above its 200-day average, the long-term trend line — a longer-term uptrend | +8.0% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $116.51 | $116.51 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $105.84 | $105.84 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that downward direction; the labelling fails if price closes above 114.29. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible downward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 40 trading days ago — a "golden cross", a bullish long-term signal | 40 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 16, below the 25 that marks a real trend) | 15.5 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 49, neither overbought (above 70) nor oversold (below 30) | 49.1 |
|---|---|---|
| Position in its 14-day range | it is trading around the middle of its 14-day range ($109.88 to $118.05) — its "stochastic" reading is 54 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 53.6 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 1 trading day ago (its momentum flipped positive) | 1 session |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $124.44 | $124.44 |
|---|---|---|
| From the 52-week high | it is 8.2% below its 52-week high (its highest price of the past year) | -8.2% |
| Above the 52-week low | it is 29.9% above its 52-week low (its lowest price of the past year) | +29.9% |
| Below the 52-week high | it is 8.2% below its highest point of the past year | 8.2% |
| Since a 20-day breakout | it made a new 20-day low about 7 trading days ago | 7 sessions |
| Since a 55-day breakout | it made a new 55-day high about 32 trading days ago | 32 sessions |
| All-time high | its highest closing price on record is $136.72 (set on 2025-01-22) | $136.72 |
| Given back of the 52-week move | over the past year its closes ranged ($88.49 to $122.75), and it has recovered well over two thirds of its fall from last year’s high — 75% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $109.66 to $110.76. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 75.2% |
| From the all-time high | it is 16.4% below its all-time high | -16.4% |
| Nearest price level | it is sitting right on a support level at $113.83 — a price it turned at 7 times since 2025-05-12, most recently on 2026-09-14. Since 2024-10-08 it has 7 such levels below the current price and 4 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.4% |
| All-time low | its lowest closing price on record is $2.80 (set on 2010-11-01) | $2.80 |
| Above the all-time low | it is 3980.7% above its all-time low | +3,981% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 32nd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $3.00 between its high and its low — about 2.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $3.00 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $109.84 and $118.93 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $109.84 – $114.39 – $118.93 |
| Typical daily range (% of price) | its price moves about 2.6% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.6% |
| Stretch from the 200-day average | it is trading 2.8 daily ranges above its 200-day average price (8.0% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 2.8 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.69× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|---|---|
| Since a bearish engulfing | 6 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 6 sessions ago |
Price gaps
2
| Gap at the open | it opened on 2026-10-08 0.1% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.1% |
|---|---|---|
| Gap filled | a 2.5% gap down opened on 2026-08-10 has been "filled" 42 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 42 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 4 sessions in a row, a +2.69% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 4 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 5.3 percentage points (the stock lost 4.2% while the market gained 1.0%) | -5.3% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 3.6 percentage points (the stock gained 7.5% while the market gained 3.8%) | +3.6% |
| vs market, 6 months | over the past 6 months this stock beat the market by 4.8 percentage points (the stock gained 22.2% while the market gained 17.5%) | +4.8% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 15.0 percentage points (the stock lost 0.0% while the market gained 15.0%) | -15.0% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, outperforming the market over 6 months — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 0 of the 9 technical signals we can compute for it are currently in a bearish state — these describe past price behaviour, not a forecast | 0 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is moderate, spanning 7.6% of the share price. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 9% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $105.10 — a volume-weighted average of daily closes over 191 sessions, not a true tick-by-tick VWAP. | +8.7% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% below the average price paid since it last reported on 2026-08-03 (its 8-K), so the typical buyer over that stretch is under water. That average is $116.40 — a volume-weighted average of daily closes over 48 sessions, not a true tick-by-tick VWAP. | -1.8% |
Price levels it has turned at before
ADUS last closed at $114.26 on 2026-10-08. Since 2024-10-08 it has turned at 7 prices below its last close and 4 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $113.83 | Support | 0.4% below the last close | turned there 7 times · 2025-05-12 to 2026-09-14 |
| $117.61 | Resistance | 2.9% above the last close | turned there 11 times · 2024-11-05 to 2026-07-17 |
| $109.90 | Support | 3.8% below the last close | turned there six times · 2025-06-02 to 2026-10-01 |
| $120.99 | Resistance | 5.9% above the last close | turned there five times · 2025-09-30 to 2026-09-10 |
| $106.56 | Support | 6.7% below the last close | turned there six times · 2025-05-15 to 2026-08-04 |
| $123.56 | Resistance | 8.1% above the last close | turned there four times · 2025-01-06 to 2026-08-20 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes above $114.29.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $112.41 and $114.29 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close below $109.88.
This reading has stood for 11 trading days, since 2026-09-24.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · MACD just crossed bullish (12/26/9) · trendless / choppy (low ADX) · Under water since its last earnings report (below the anchored VWAP) · Trading inside the Ichimoku cloud · Near a support level (sitting on a price it has bounced off before) | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.71 mean, 1=Strong Buy…5=Strong Sell) — 13 analysts
- Mean price target$133.69 range $96.00 – $155.00; median $136.00
Analyst estimates, as of 2026-10-07. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ADUS
- Consensus EPS estimate$1.79 next reporting period, as of 2026-10-07
- Estimate change, 30 days+$0.00139 (+0.1%) from $1.79, on 2026-09-06, 31-day window
- Readings revised upward33% of 9 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Heavy dependence on government-funded programs like Medicaid and Medicare for revenue.","Highly fragmented and competitive industry with increasing regulatory, licensure, and operational compliance requirements.","Reliance on successful integration and realization of synergies from strategic acquisitions to drive growth."]
What changed in the latest 10-Q
AI-assisted comparison of ADUS's 10-Q filed 2026-08-04 against the prior one filed 2026-05-05.
Risk Factors
- Added:
- In the filing dated 2026-08-04, Item 5 adds the statement 'Not applicable. Without limiting the generality of the foregoing, during the quarter ended June 30, 2026, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements, as such terms are defined in Item 408(a) of Regulation S-K.'
- Removed:
- In the filing dated 2026-05-05, Item 5 included a table listing Rule 10b5-1 Trading Arrangements adopted by directors and Section 16 officers during the quarter ended March 31, 2026, with named individuals, titles, adoption dates, expiration dates, and share amounts; this table is absent from the filing dated 2026-08-04.
- In the filing dated 2026-05-05, Item 5 included footnotes (1) and (2) explaining plan expiration and sell-to-cover share amounts; these footnotes are absent from the filing dated 2026-08-04.
- In the filing dated 2026-05-05, Item 5 included a statement that each trading arrangement was intended to satisfy the affirmative defense in Rule 10b5-1(c); this statement is absent from the filing dated 2026-08-04.
- Reworded:
- In the filing dated 2026-05-05, Item 5 reported disclosures for 'the quarter ended March 31, 2026' regarding trading arrangements; the filing dated 2026-08-04 reports for 'the quarter ended June 30, 2026'.
- Notes:
- The text provided for the newer and older filings includes the broader section beginning at 'Item 1A. Risk Factors' and extending through signatures, although the requested section was 'Risk Factors.'
- The Risk Factors section text itself (Item 1A) is identical between the two filings.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 180 days · read to 2026-10-040 buys · 4 sells ($90168) — 3 selling insiders
Most recent open-market transaction: 2026-06-22. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ADUS's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding ADUS as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 4,822,813
- Reported value $484,534,756
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about ADUS's institutional holders → See what each manager we track holds →
Short interest (FINRA)
ADUS had 879,964 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
ADUS had 4.71% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.45 days to cover at the same settlement.
- Reported short interest (shares) 879,964
- Short interest (% of shares outstanding) 4.71%
- Prior settlement (shares) 895,318
- Reported change -1.71%
- Days to cover (reported) 4.45
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Amedisys (AMED)
- Encompass Health (EHC)
- The Pennant Group (PNTG)
- Gentiva Health Services
- Brookdale Senior Living (BKD)
- Aveanna Healthcare (AVAH)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ADUS vs…
ADDUS HOMECARE CORP is found in…
Frequently asked questions
What does ADDUS HOMECARE CORP (ADUS) do?
Addus HomeCare provides personal care, hospice, and home health services to elderly and infirm individuals, primarily through in-home care delivery. The company serves a predominantly dual-eligible population (Medicare and Medicaid) and focuses on enabling clients to maintain independence at home while lowering overall healthcare costs by preventing institutionalization. Addus operates across 23 states and actively pursues growth through both organic means and strategic acquisitions.
What sector is ADDUS HOMECARE CORP (ADUS) in?
ADDUS HOMECARE CORP (ADUS) is classified in the Health Care sector. Its industry is Home health and hospice care services. It trades on NASDAQ.
Who are ADDUS HOMECARE CORP's (ADUS) competitors?
Notable peers of ADDUS HOMECARE CORP (ADUS) include Amedisys, Encompass Health, The Pennant Group, Gentiva Health Services and Brookdale Senior Living. This peer set is informational only — not financial advice.
Is ADDUS HOMECARE CORP (ADUS) overbought or oversold right now?
ADDUS HOMECARE CORP (ADUS) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 49, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ADUS come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.